Clinical trial
Study on the Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Steroid - Dependent /Steroid-resistant Nephrotic Syndrome in Children
NCT07003438 is registered in ClinicalTrials.gov with Zhang Ting as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on the Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Steroid - Dependent /Steroid-resistant Nephrotic Syndrome in Children
- Lead sponsor
- Zhang Ting
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- June 1, 2025
- Completion date
- April 1, 2028
- Enrollment
- 120 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
steroid-dependent nephrotic syndrome, steroid-resistant nephrotic syndrome